EP2806859
Efnasamsetning 3-(6-(1-(2.2-tvíflúorbensó[D][1,3]tvíoxól-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) bensósýru
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.1.2013EP published:
15.5.2019EP application number:
13703243.9
EP translation filed:
12.8.2019Grant published:
15.9.2019EPO information:
European Patent Register
Max expiry date:
24.1.2033Expiry date:
24.1.2027Next due date:
31.1.2027
Title:
FORMULATIONS OF 3-(6-(1-(2.2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID
Timeline
Today
25.1.2013EP application
15.5.2019EP Publication
12.8.2019Translation submitted
15.9.2019Registration published
24.1.2027Expires
Owner
Name:
Vertex Pharmaceuticals IncorporatedAddress:
50 Northern Avenue, 02210, Boston, MA, US
Inventor
Name:
VERWIJIS, Marinus, JacobusAddress:
Framingham, MA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261590479 PDate:
25.1.2012Country:
US
Number:
201261651218 PDate:
24.5.2012Country:
US
Number:
201261691898 PDate:
22.8.2012Country:
US
Number:
201261708691 PDate:
2.10.2012Country:
US
Classification
Categories:
A61K 9/16, A61K 9/20, A61K 9/28, C07D 213/75, C07D 405/12, C07D 405/14, A61K 31/443
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 3.1.2020
Expires: 24.1.2021
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 31.12.2020
Expires: 24.1.2022
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 31.12.2021
Expires: 24.1.2023
Payer: Patice ehf.
Number: 11
Paid: 3.1.2023
Expires: 24.1.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 4.1.2024
Expires: 24.1.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 8.1.2025
Expires: 24.1.2026
Payer: Árnason Faktor ehf.
Number: 14
Paid: 20.1.2026
Expires: 24.1.2027
Payer: Árnason Faktor ehf.